Aquavit Pharmaceuticals, Inc. Adds New Patent to Its High-Tech Medical Portfolio
NEW YORK, Aug. 31, 2017 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office (USPTO) has issued a patent for Apollo Technology™, System and Method for Personalized Injection Treatment (PITO-001: Patent # 9,675,519). This follows...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]dical-portfolio-300512534.html
